Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Fall 2019 - Innovation
Download Issue
Share
Up Front
Publisher's Corner
Innovative Technologies Improve Patient Care
By Patrick M. Schmidt
Features
Opioid Dependence in Infants: A Growing Crisis
By
Trudie Mitschang
The Growing Need for Supportive Care in Oncology
By
Diane L.M. Cook
Myths and Facts: Shingles
By
Ronale Tucker Rhodes, MS
Nutrigenomics: How Genes and Nutrition Interact
By
Amy Scanlin, MS
Stopping Alzheimer’s with a Preventative Vaccine?
By
Diane L.M. Cook
The Future of Medicine with Artificial Intelligence
By
Meredith Whitmore
BioTrends Watch
Washington Report
HHS Grants Additional Money to Expand Access to Effective Opioid Treatment
FDA Seeks to Enhance Clinical Trial Diversity with New Guidance
New CMMI Direct-Contracting Pay Models Will Overhaul Fee-for-Service Models
Reimbursement FAQs
CMS 2020 Proposed and Final OPPS and ASC Rules
Healthcare Management
Streamlining Patient Visits
Industry News
ADMA Biologics Receives U.S. Patent for Treatment and Prevention of Pneumococcal Infections
Researchers Develop Vaccine Candidates to Prevent Epstein-Barr Virus
Sanofi Receives Narrow FDA Approval for Dengue Vaccine
Campaign Launched to Remind Families Teens Need Second Meningitis Booster Shot
FDA Approves Expanded Use of Doptelet to Treat Thrombocytopenia
Connecting with People Who Have Suffered from Diseases Can Change Attitudes Toward Vaccines
Genetics Linked to Immunity to Childhood Vaccines
2018-19 Flu Season Separated by Two Waves Was Longest in Decade
FDA Approves Pediatric Hexavalent Combination Vaccine
Researchers Discover New, Rare Autoimmune Disease
Flu Pamphlet Impacts Parents' Decision to Vaccinate Kids
BioFocus
Industry Insight
Agents That Block Plasma IgG Recycling: The Next Big Thing for IgG Antibody-Mediated Diseases?
By Keith Berman, MPH, MBA
Patient Profile
Prostheses: A Patient's Perspective
By Trudie Mitschang
Physician Profile
Prostheses: An Expert’s Perspective
By Trudie Mitschang
Disease Profile
Update on Toxic Shock Syndrome
By Jim Trageser
BioSources
BioResearch
SCIG with Recombinant Human Hyaluronidase Is Safe and Preferred vs IVIG by Some Multifocal Motor Neuropathy Patients
Patients on IVIG Therapy for Neurological Disorders Successfully Transitioned to SCIG Therapy